Nectero Medical Inc — Form D
Nectero Medical Inc of Tempe, AZ, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-10. The offering totals $96.6M, of which $32.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-05-10
- Form: D
- Accession: 0001810951-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $96.6M
- Amount sold: $32.8M
- Remaining: $63.8M
- Investors: 30
- Date of first sale: 2024-04-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-512920
Issuer
- Name: Nectero Medical Inc
- CIK: 0001810951
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 2343 W. University Drive, Tempe, AZ, 85281
- Phone: 866-755-4744
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Anil Dasu | Director | Tempe, AZ |
| Colin Morrison | Director | Plymouth, MN |
| Bruce Roberts | Director | Brevard, NC |
| Jack Springer | Director | Tempe, AZ |
| Robert Whirley | Director | Tempe, AZ |
| Jack Springer | Executive Officer | Tempe, AZ |
| Bryan Ziegler | Executive Officer | Houston, TX |
| John Springer | Director | Bethlehem, PA |
| John Springer | Executive Officer | Bethlehem, PA |
Other filings by this issuer (2)
More